NHS England Treats First Sickle Cell Patients with 'Life-Changing' Drug
Around 5000 patients are likely to benefit from the drug over the next 3 years.
Source: medscape.com
Stay updated with breaking news from Managed Access Agreement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Around 5000 patients are likely to benefit from the drug over the next 3 years.
Managed access agreement treatment eligibility criteria extended following review - News - PharmaTimes